Medical Microbiology
A section of Microorganisms (ISSN 2076-2607).
Section Information
This Section will focus on research in infectious diseases, pathogenic microorganisms-hosts interaction, bacteriology, mycology, virology and parasitology, including immunology and epidemiology as related to these fieldsthese field and all microbial pathogens as well as the microbiota and its effect on health and disease in various hosts.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Understanding Dissemination of Mycobacterium tuberculosis (Deadline: 15 October 2023)
- The Role of Microorganism in Gestational Diabetes Mellitus 2.0 (Deadline: 30 October 2023)
- Humanised Mouse Models: Recent Advances in Human Infectious Diseases (Deadline: 30 October 2023)
- Forensic Microorganism (Deadline: 31 October 2023)
- Nontuberculous Mycobacteria: Recent Advancements in Infection, Diagnosis and Therapy (Deadline: 31 October 2023)
- Female Urogenital Microbiome in Health and Disease (Deadline: 31 October 2023)
- Microbiome in Infectious Diseases (Deadline: 31 October 2023)
- Healthcare-Associated Infections and Antimicrobial Therapy (Deadline: 31 October 2023)
- Development of COVID-19/SARS-CoV-2 Therapeutic Options (Deadline: 31 October 2023)
- Nontuberculous Mycobacteria: Emerging Diseases and Health Impacts 2.0 (Deadline: 31 October 2023)
- Diagnosis, Characterization and Treatment of Emerging Pathogens (Deadline: 31 October 2023)
- Effects of Respiratory Viral Infections on the Nervous System (Deadline: 31 October 2023)
- Emerging Microbial-Resistant Pathogens: Updates on Clinical, Epidemiological, and Molecular Perspectives (Deadline: 31 October 2023)
- Anti-inflammatory Property of Probiotics (Deadline: 31 October 2023)
- Ocular Microbial Infections (Deadline: 1 November 2023)
- Cryptococcosis Associated/Co-infected with Other Diseases (Deadline: 15 November 2023)
- Surveillance of Viral Epidemics (Deadline: 15 November 2023)
- Emerging and Re-emerging Infectious Diseases: Recent Developments on Therapeutics, Clinical Epidemiology and Transmission (Deadline: 15 November 2023)
- Challenges in the Management of Infectious Complications in Neutropenic Cancer Patients (Deadline: 15 November 2023)
- Safety of Platelet Components: Past, Present and Future (Deadline: 20 November 2023)
- Microbial Interactions including Candida concerning Health and Disease (Deadline: 30 November 2023)
- Acanthamoeba spp. as Factors for Severe Infectious Diseases in Humans, 2nd Edition (Deadline: 30 November 2023)
- Novel Molecular Diagnostic Methods of Clinical Disease (Deadline: 30 November 2023)
- Molecular Epidemiology of Clostridium difficile (Deadline: 30 November 2023)
- Bacterial Pathogens Associated with Bacteremia (Deadline: 30 November 2023)
- Kingella kingae: Virulence Factors, Clinical Disease, and Diagnostics (Deadline: 30 November 2023)
- Gut Microbiome in Rheumatoid Arthritis (Deadline: 30 November 2023)
- Emerging Pathogens Causing Acute Hepatitis (Deadline: 30 November 2023)
- Role of Microbiome in Lung Health (Deadline: 30 November 2023)
- Human Skin Microbiota 2.0 (Deadline: 30 November 2023)
- Advances in Campylobacter: Molecular Epidemiology, Virulence Factors, Immune Response and Drug Resistance (Deadline: 30 November 2023)
- Emerging Pathogens in the Context of One Health (Deadline: 30 November 2023)
- Influenza Prevention: Exploring the Progress and Persevering through Challenges (Deadline: 30 November 2023)
- Recent Advances of Respiratory Infections, Second Edition (Deadline: 30 November 2023)
- Role of Oral Microbiota in Oral and General Health in Adults and Children (Deadline: 30 November 2023)
- Device-Related Infections and Bacterial Biofilms (Deadline: 30 November 2023)
- Mycobacterium abscessus: Current Knowledgement on an Emerging Pathogen (Deadline: 15 December 2023)
- Sepsis and Septic Shock (Deadline: 15 December 2023)
- Recent Advances in Coxsackievirus Infections: Epidemiology, Pathogenesis and Methods for Control and Prevention (Deadline: 15 December 2023)
- Prevention and Treatment of Helicobacter pylori Infection Related Gastrointestinal Disease (Deadline: 15 December 2023)
- Microbiome and Pneumonia (Deadline: 15 December 2023)
- Ocular Infections and Microbiota in Health and Disease 2.0 (Deadline: 30 December 2023)
- Biology and Pathogenesis of Staphylococcus Infection 2.0 (Deadline: 30 December 2023)
- Applied Microbiome Science and Technology (Deadline: 31 December 2023)
- Virulence and Resistance of Klebsiella pneumoniae 2.0 (Deadline: 31 December 2023)
- Infections in Pregnancy and Pathology Findings, 2nd Edition (Deadline: 31 December 2023)
- Vaginal Microbiome in Women's Health (Deadline: 31 December 2023)
- Oral, Dental, and Periodontal Microorganisms of the Oral Cavity: Physiological Conditions, Pathologies and Preventive and Therapeutic Approaches (Deadline: 31 December 2023)
- Bartonella and Bartonellosis: New Advances and Further Challenges (Deadline: 31 December 2023)
- Aquatic Foodborne Pathogen and Antibiotic Resistance (Deadline: 31 December 2023)
- Microbiology of Oral Diseases 2.0 (Deadline: 31 December 2023)
- Biomarkers in Oral Health and Diseases: New Advances and Treatment Strategies (Deadline: 31 December 2023)
- Microorganisms Associated with Infectious Disease 2.0 (Deadline: 31 December 2023)
- Infectious Eye Diseases and Prevention Control (Deadline: 31 December 2023)
- New Trends in Medical Bacteriology: Diagnosis, Treatment and Prevention (Deadline: 15 January 2024)
- Mycobacterial Tuberculosis Pathogenesis and Vaccine Development (Deadline: 15 January 2024)
- Epidemiology of SARS-CoV-2/COVID-19 Infections (Deadline: 15 January 2024)
- Microbial Infections and Rheumatic Diseases (Deadline: 15 January 2024)
- Prevention and Treatment of Healthcare-Associated Infections (Deadline: 31 January 2024)
- Advances in Brucella (Deadline: 31 January 2024)
- Oral Microbes and Human Health (Deadline: 31 January 2024)
- State-of-the-Art Medical Microbiology in Italy (2023–2024) (Deadline: 31 January 2024)
- Epidemiology and Pathogenesis of Human Enteroviruses 2.0 (Deadline: 31 January 2024)
- Advances in Enterovirus and Type 1 Diabetes (Deadline: 31 January 2024)
- Advances in Cutaneous Mycosis (Deadline: 31 January 2024)
- Monitoring and Epidemiology of Foodborne Pathogens and Zoonoses (Deadline: 31 January 2024)
- Infection and Virulence of Pathogenic Bacteria (Deadline: 31 January 2024)
- Role of Microbiota in Cardiovascular Diseases (Deadline: 31 January 2024)
- Extracellular Vesicles in Pathogens (Deadline: 15 February 2024)
- Group A Streptococcus: Infection, Immunity and Vaccine Development (Deadline: 15 March 2024)
- Detection and Analysis of Clinical Microbial Infections (Deadline: 15 March 2024)
- State-of-the-Art Medical Microbiology in the USA (2023, 2024) (Deadline: 31 March 2024)
- Bacteria Control by Phages (Deadline: 31 March 2024)
- Leaky Skin Syndrome (Deadline: 31 March 2024)
- Overview of Sepsis and Septic Shock (Deadline: 31 March 2024)
- Infections in Solid Organ Transplant Recipients (Deadline: 31 March 2024)
- Pseudomonas aeruginosa: Pathogenicity, Drug Resistance Mechanisms and Interaction with the Host (Deadline: 31 March 2024)
- Advance in Microbial Pathogen Diagnosis (Deadline: 31 March 2024)
- Virus-Driven Skin Diseases (Deadline: 31 March 2024)
- Candida Species Virulence Factors and Their Pathogenicity (Deadline: 30 April 2024)
- Chlamydiae & Chlamydia-Likes 2024 (Deadline: 15 June 2024)
- State-of-the-Art Medical Microbiology in UK (2023, 2024) (Deadline: 30 June 2024)
- State-of-the-Art Medical Microbiology in Italy (2023, 2024) (Deadline: 30 June 2024)
- State-of-the-Art Medical Microbiology in Japan (2023, 2024) (Deadline: 30 June 2024)
- The Infective Endocarditis (Deadline: 31 July 2024)
